uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted June 24, 2010

FDA Warns Seller of Pills Used to Treat Autism

On June 17, 2010 the U.S. Food and Drug Administration (FDA) sent a Warning Letter of legal violations to CTI Science, Inc., the marketer of OSR#1. The product is marketed as a supplement, but contains an ingredient that is not legally permitted to be sold as a supplement.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at